[法国的妊娠与物质使用：文献综述]

[Pregnancy and substance use in France: a literature review].

作者信息

Dumas A, Simmat-Durand L, Lejeune C

机构信息

EHESS, CNRS UMR 8211, Inserm U 988, université Paris Descartes, Cermes 3, 45, rue des Saints-Pères, 75270 Paris cedex 06, France.

出版信息

J Gynecol Obstet Biol Reprod (Paris). 2014 Nov;43(9):649-56. doi: 10.1016/j.jgyn.2014.05.008. Epub 2014 Jun 12.

DOI:10.1016/j.jgyn.2014.05.008

PMID:24930726

Abstract

OBJECTIVES

Substance use during pregnancy is an important public health issue. It requires identifying at-risk populations and risk perception among women.

MATERIALS AND METHODS

A literature review was conducted. It included French studies conducted since 2000 on substance use during pregnancy (tobacco, alcohol, marijuana, psychotropic drugs) and risk perception.

RESULTS

In France, in 2010, 24% of pregnant women smoke--17% in the 3rd trimester. Depending on studies, the prevalence of alcohol use ranged from 12 to 63% and binge drinking ranged from 1 to 7%; daily drinking was below 0.5%. Marijuana use ranged from 1 to 3%, and psychotropic drugs ranged from 2 to 4%. Little research has been dedicated to risk perception. Studies show a lack of awareness about the equivalence of risks between fermented and distilled beverages and about the risks of moderate smoking during pregnancy.

CONCLUSION

Data is lacking to characterize at-risk populations and mechanisms underlying risky behaviors.

摘要

目标

孕期物质使用是一个重要的公共卫生问题。这需要识别高危人群以及女性中的风险认知情况。

材料与方法

进行了一项文献综述。纳入了自2000年以来法国开展的关于孕期物质使用（烟草、酒精、大麻、精神药物）及风险认知的研究。

结果

在法国，2010年，24%的孕妇吸烟——孕晚期为17%。根据研究，酒精使用的患病率在12%至63%之间，暴饮的患病率在1%至7%之间；每日饮酒低于0.5%。大麻使用在1%至3%之间，精神药物使用在2%至4%之间。很少有研究致力于风险认知。研究表明，人们对发酵饮料和蒸馏饮料风险的等同性以及孕期适度吸烟的风险缺乏认识。